financout seems as if that is all the management cares about , or else they would be willing to take a smaller slice of the pie if it meant curing cancer sooner. Kane stated they would rather wait until they can fund the trials themselves instead of getting money from an investor which would cut into their future earnings. And since I already pointed out, the only ones who will get any share of the profits will be the class a shares, which is what they would be giving to a significant financier.
Of course all of my post are my own personal opinion which may change at any given notice.